ArticleCancer biology & therapy2008
New insights into the role of CXCR4 in prostate cancer metastasis.
Article in Cancer biology & therapy, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.
- The association of CXCR4 expression with clinicopathological significance and potential drug target in prostate cancer: a meta-analysis and literature review.Drug design, development and therapy · 2015Pooled it
- Circulating tumour cells as a window into lethality in prostate cancer.Nature reviews. Urology · 2026Review
- Investigation of the Immunomodulatory Effect of Quinoline Derivatives with Antitumor Activity.Anti-cancer agents in medicinal chemistry · 2026Article
- Prostate Cancer Imaging Beyond PSMA: Applications of GRPR, AR, and Amino Acid Tracers.Diagnostics (Basel, Switzerland) · 2025Review
- Tumor cells express and maintain HMGB1 in the reduced isoform to enhance CXCR4-mediated migration.Frontiers in immunology · 2024Article
- Cancer-Associated Fibroblast Heterogeneity, Activation and Function: Implications for Prostate Cancer.Biomolecules · 2022Review
- Functionalized nanoparticles targeting biomarkers for prostate cancer imaging and therapy.American journal of clinical and experimental urology · 2022Review
- At the Bench: Pre-clinical evidence for multiple functions of CXCR4 in cancer.Journal of leukocyte biology · 2021Review
- Cytokines and Chemokines as Mediators of Prostate Cancer Metastasis.International journal of molecular sciences · 2020Review
- Paradoxical Role of Glypican-1 in Prostate Cancer Cell and Tumor Growth.Scientific reports · 2019Article
- CARMA3 Is a Critical Mediator of G Protein-Coupled Receptor and Receptor Tyrosine Kinase-Driven Solid Tumor Pathogenesis.Frontiers in immunology · 2018Review
- Prostate Cancer Imaging and Biomarkers Guiding Safe Selection of Active Surveillance.Frontiers in oncology · 2017Review
- Rituximab for treating CD20+ prostate cancer with generalized lymphadenopathy: a case report and review of the literature.Investigational new drugs · 2014Review
- Redox-mediated and ionizing-radiation-induced inflammatory mediators in prostate cancer development and treatment.Antioxidants & redox signaling · 2014Review
- The intricate role of CXCR4 in cancer.Advances in cancer research · 2014Review
- Expression of CD26 and CXCR4 in prostate carcinoma and its relationship with clinical parameters.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2013Article
- Small molecule inhibitors of CXCR4.Theranostics · 2013Review
- Gossypol inhibits growth, invasiveness, and angiogenesis in human prostate cancer cells by modulating NF-κB/AP-1 dependent- and independent-signaling.Clinical & experimental metastasis · 2012Article
- SLUG promotes prostate cancer cell migration and invasion via CXCR4/CXCL12 axis.Molecular cancer · 2011Article
- Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer.Neoplasia (New York, N.Y.) · 2011Review
Corrections and comments
- Comment on
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.